Tilray, Inc. (NASDAQ:TLRY) is expected to report third quarter earnings results, after market close, on Monday 9th November 2020.
Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.21 per share.
Looking ahead, the full year loss are expected at $ 2.65 per share on the revenues of $ 219.99 million.
Previous Quarter Performance
Tilray, Inc. reported loss for the second quarter of $ 0.43 per share, from the revenue of $ 50.41 million. The quarterly revenues swell 22.62 percent compared with the same quarter last year. According to street consensus, TLRY was expected to report 2Q20 loss of $ 0.27 per share from revenue of $ 55.02 million. The bottom line results missed street analysts by $ 0.16 or 59.26 percent, at the same time, top line results fell short of analysts by $ 4.61 million or 8.38 percent.
Stock Performance
On Friday, shares of Tilray, Inc. has traded high as $ 12.14 and has cracked $ 8.45 on the downward trend, reaching $ 9.63 with volume of 116.42 million shares.
According to the previous trading day, closing price of $ 9.63, representing a 221.81 % increase from the 52 week low of $ 2.43 and a 67.14 % decrease over the 52 week high of $ 23.80.
The company has a market capital of $ 1.28 billion and is part of the Healthcare sector and Drug Manufacturers – Specialty & Generic industry.
Recent Analyst recommendations
- On 21st September 2020, upgraded by Jefferies Financial Group to Hold from Underperform rating.
Conference Call
Tilray, Inc. will be hosting a conference call at 5:00 PM eastern time on 9th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.tilray.com
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, and compassionate access and clinical research applications.
